Publications:17
- Home
- Profiles
Mount Sinai DoctorsBrandon M Veremis, DDS
No Patient Experience Ratings
- About Me
- Education & Certifications
- Insurance
- Publications
- Industry Relationships
About Me
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
About Me
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
Education
Residency, Dentistry
University of Toledo Health Science Campus
Residency, Oral & Maxillofacial Surgery
Icahn School of Medicine At Mount Sinai
Certifications
American Board of Oral & Maxillofacial Pathology
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- A clinical benchmark of public self-supervised pathology foundation models. Gabriele Campanella, Shengjia Chen, Manbir Singh, Ruchika Verma, Silke Muehlstedt, Jennifer Zeng, Aryeh Stock, Matt Croken, Brandon Veremis, Abdulkadir Elmas, Ivan Shujski, Noora Neittaanmäki, Kuan Lin Huang, Ricky Kwan, Jane Houldsworth, Adam J. Schoenfeld, Chad Vanderbilt. Nature Communications
- Consensus in Oral Epithelial Dysplasia Classification: A Comparative Analysis of H&E-stained Sections With and Without p53/p16 Immunohistochemistry. Ivan J. Stojanov, Kelly Yi Ping Liu, Christina Mccord, Julia Yu Fong Chang, Yi Ping Wang, Chia Cheng Li, Lingxin Zhang, Victoria L. Woo, Elizabeth M. Philipone, Paras B. Patel, Kelly R. Magliocca, Iona Leong, Hemlata Shirsat, Vincent Cracolici, Christopher C. Griffith, William H. Westra, Emilija Todorovic, Elizabeth A. Bilodeau, William C. Faquin, Lynn N. Hoang, Ilena S. Yim, Natyra Haxhiavdija, Martial Guillaud, Brandon M. Veremis, Yen Chen Kevin Ko. American Journal of Surgical Pathology
- The Common Expression of INSM1 in HPV-related Oropharyngeal Squamous Cell Carcinomas Is Not Associated With True Neuroendocrine Transformation or Aggressive Behavior. Swati Bhardwaj, Brandon Veremis, Rocco Fernandino, Marshall Posner, William H. Westra. American Journal of Surgical Pathology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Veremis did not report having any of the following types of financial relationships with industry and other outside entities during 2024 and/or 2025: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Veremis did not report having any of the following types of financial relationships with industry and other outside entities during 2024 and/or 2025: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.